Introduction
============

Central spinal stenosis is the narrowing of the spinal canal with encroachment on the neural structures by surrounding bone and soft tissues prevalent in 27.2% of the population [@B1],[@B2]. Spinal stenosis may, however, be asymptomatic in many cases despite radiological diagnosis [@B3],[@B4]. Symptoms of central spinal stenosis may be related to a neurovascular mechanism such as reduced arterial flow in cauda equina, venous congestion, and increased epidural pressure [@B5]-[@B13], nerve root excitation by local inflammation, or direct compression in the central canal [@B5],[@B10]. Consequently, spinal stenosis is a multifactorial disorder and clinical presentation can be variable with or without neurogenic claudication manifested by pain in the buttocks or legs when walking, which disappears with sitting or lumbar flexion [@B5],[@B11],[@B12]. There is no gold standard or valid diagnostic test for concluding that spinal stenosis is the cause of pain in a given patient [@B13]. In fact, a systematic literature review [@B14] of the quantitative radiologic criteria for the diagnosis of lumbar spinal stenosis of 25 studies reporting on radiological signs of lumbar spinal stenosis and 4 systematic reviews related to the evaluation of different treatments showed 10 different parameters identified to quantify lumbar spinal stenosis. Spinal stenosis is the most common reason for lumbar spine surgery in persons older than 65 years in the United States [@B15]-[@B23]. The failure of conservative management leads to decompressive surgery with or without fusion. A systematic review comparing surgery versus conservative treatment for symptomatic lumbar spinal stenosis [@B5] concluded that in patients with symptomatic lumbar spinal stenosis, the implantation of a specific type of device or decompressive surgery, with or without fusion, is more effective than continued conservative treatment when the latter has failed for 3 to 6 months. However, in this systematic review, epidural steroids and adhesiolysis were not properly assessed.

In another systematic review describing non-operative treatment of lumbar spinal stenosis in patients with neurogenic claudication [@B17], the authors concluded that there was very low quality evidence from a single trial that epidural steroid injections improve pain, function, and quality of life for up to 2 weeks when compared with home exercise or inpatient physical therapy. There were no adhesiolysis studies included. Consequently, they concluded that moderate- and high-grade evidence for non-operative treatment was lacking and thus prohibiting recommendations to guide clinical practice. Once again, the authors did not utilize the available studies in evidence synthesis, leading to unfounded conclusions. The improper evaluation of available literature in managing spinal stenosis with epidural injections was also illustrated in a protocol for lumbar epidural steroid injections for spinal stenosis [@B12]. However, recent systematic reviews performed showed fair evidence for managing central lumbar spinal stenosis with caudal, interlaminar, and transforaminal epidural injections and percutaneous adhesiolysis [@B24]-[@B27]. Furthermore, there have been multiple publications showing evidence of the effectiveness of epidural injections in managing spinal stenosis [@B28]-[@B31].

Thus, spinal stenosis is commonly managed by various conservative modalities, interventional techniques, and surgical interventions [@B5],[@B15]-[@B45]. Since the relief from epidural injections is only modest in patients suffering from spinal stenosis, the next alternative is percutaneous adhesiolysis. A preliminary report of percutaneous adhesiolysis in patients with central lumbar stenosis after failure of fluoroscopically directed caudal epidural injections evaluating 50 patients showed significant improvement in 76% of patients undergoing percutaneous adhesiolysis. However, this study was hampered by a small sample size [@B32]. Caudal epidural steroid injections have been shown to be with significant improvement in approximately 50% of the patients [@B25],[@B28]; however, a preliminary report [@B29] of lumbar interlaminar epidural injections in central spinal stenosis showed better results with a small sample size. It remains to be seen if these results continue to be maintained with subsequent follow-up with appropriate sample sizes. Percutaneous adhesiolysis is employed to facilitate targeted delivery and has been shown in multiple publications to be effective in post surgery syndrome [@B27],[@B43]-[@B46].

This study is undertaken to evaluate the role of percutaneous adhesiolysis with hypertonic sodium chloride solution in patients with chronic intractable pain secondary to lumbar central spinal stenosis. This study is a continuation of preliminary results of a randomized trial [@B32] with 25 patients followed prospectively for 2 years, along with additional 45 patients prospectively evaluated for 2 years.

Materials and Methods
=====================

The initial part of the study was conducted according to Consolidated Standards of Reporting Trials (CONSORT) guidelines [@B47]. The study was performed in an interventional pain management practice, a specialty referral center, in the United States, in a private practice setting. The study protocol was approved by the Institutional Review Board (IRB) and was registered on the U.S. Clinical Trial Registry with an assigned number of NCT00370994. This study was conducted with internal resources of the practice without any external funding either from industry or from elsewhere.

The study was designed to assess 120 patients with 60 patients in each group. The randomized portion was conducted over a period of one year with the publication of preliminary results with 25 patients in each group [@B32]. However, due to the difficulties of recruiting patients into a double-blind randomized trial with a high unblinding or withdrawal rate, 25 patients in the intervention group receiving percutaneous adhesiolysis were unblinded and were subsequently followed for 2 years. In addition, 45 patients were recruited into the prospective observational phase of the study with a total of 70 patients.

Patients
--------

All patients were drawn from a single pain management practice. All patients signed an appropriate informed consent to participate in the study.

### Pre-Enrollment Evaluation

The pre-enrollment evaluation included demographic data, medical and surgical history with coexisting disease(s), radiologic investigations, physical examination, pain rating scores using the Numeric Rating Scale (NRS), work status, opioid intake, and functional status assessment by the Oswestry Disability Index 2.0 (ODI).

Inclusion Criteria
------------------

Inclusion criteria were diagnosis of lumbar central spinal stenosis with radicular pain, patients over the age of 30 years; patients with a history of chronic function-limiting low back pain and lower extremity pain of at least 6 months duration; and patients who were competent to understand the study protocol and provide voluntary, written informed consent and participate in outcome measurements.

Further inclusion criteria included patients who have failed to improve substantially with conservative management including, but not limited to, physical therapy, chiropractic manipulation, exercises, drug therapy, and bed rest. All these patients had also failed to respond appropriately to fluoroscopically directed epidural injections.

Exclusion criteria were history of previous surgery, foraminal stenosis, uncontrollable or unstable opioid use, uncontrolled psychiatric disorders, uncontrolled medical illness, either acute or chronic, any conditions that could interfere with the interpretation of the outcome assessments, pregnant or lactating women, and patients with a history or potential for adverse reaction(s) to local anesthetics or steroids.

Description of Interventions
----------------------------

After the identification of filling defects, the Racz catheter was advanced through the RK needle (Epimed International, Farmers Branch, TX, USA) to the area of the filling defect or the site of stenosis as determined by magnetic resonance imaging (MRI), computed tomography (CT), or symptomatology. Appropriate adhesiolysis was carried out and the final positioning was achieved in the epidural space and into the lateral and ventral epidural space. After satisfactory positioning, at least 3 to 5 mL of contrast was injected. If there was no subarachnoid, intravascular, or other extra-epidural filling and satisfactory filling was obtained with epidural and targeted nerve root filling, 5 mL of 2% preservative free Xylocaine was injected.

In the recovery room, after 10 to 15 minutes of monitoring, an injection of sodium chloride solution 10% was administered by repeated injections in doses of 3 mL twice, followed by an injection of 6 mg of nonparticulate betamethasone and 1 mL of sodium chloride solution with the removal of the catheter. The patient was ambulated if all parameters were satisfactory. Intravenous access was removed and the patient was discharged home with appropriate instructions. Repeat percutaneous adhesiolysis injections were provided based on the response to the prior injection as evaluated by improvement in physical and functional status, followed by increased levels of pain being reported and deteriorating relief and/or a deterioration in functional status below 50%.

Co-Interventions
----------------

Most patients were receiving opioid and non-opioid analgesics as well as adjuvant analgesics. Some were involved in a therapeutic exercise program. All patients continued previously directed exercise programs, as well as their work. Thus, in this study, there was no specific physical therapy, occupational therapy, bracing, or other interventions offered other than the study intervention.

Objectives
----------

The study was designed to evaluate the effectiveness of percutaneous adhesiolysis in managing chronic low back and lower extremity pain in patients with lumbar central spinal stenosis by providing effective and long-lasting pain relief over a period of 2 years.

Outcomes
--------

Multiple outcome measures were utilized including the NRS (0-10 scale) pain scale, the ODI on a 0-50 scale, employment status, and opioid intake in terms of morphine equivalents, with assessment at 3, 6, 12, 18, and 24 months post-treatment. The NRS represented no pain with a 0 and the worst pain imaginable with a 10. The ODI was utilized for functional assessment. The value and validity of the NRS and ODI have been reported [@B48],[@B49].

The primary outcome measure was at least 50% improvement of NRS and ODI scores.

Based on the dosage frequency and schedule of the drug, the opioid intake was converted to morphine equivalents [@B50].

Rather than including all of the patients participating in the study as employable, employment and work status were determined based on employability at the time of enrollment. Employment and work status were classified into multiple categories such as employable, housewife with no desire to work outside the home, retired, or over the age 65. Patients who were unemployed due to pain, or employed but on sick leave or laid off but actively pursuing employment opportunities, were considered as employable.

Multiple thresholds for clinically important differences in the evaluation of NRS and ODI have been described [@B24]-[@B27],[@B49],[@B51]-[@B53]. For this evaluation, a robust measure of significant improvement with 50% pain relief and reduction in disability scores was utilized [@B28],[@B29],[@B54]-[@B63].

Statistical Methods
-------------------

For testing the differences in proportions, chi-squared statistic was used. Wherever the expected value was less than 5, Fisher\'s exact test was used; a paired t-test was used to compare the pre- and post treatment. Because the outcome measures of the participants were measured at 6 points in time, repeated measures analysis of variance were performed with the post hoc analysis. A *P* value of 0.05 was considered as significant.

Intent-to-Treat-Analysis
------------------------

An intent-to-treat-analysis was performed. Either the last follow-up data or initial data was utilized in the patients who dropped out of the study, and no other data were available.

Results
=======

Participant Flow
----------------

A total of 70 patients were included. Of these, 25 patients were from the randomized, controlled percutaneous adhesiolysis trial whereas the remaining 45 patients were recruited in the observational phase. Of the 70 patients, one patient died after 18 months, one patient withdrew from the study, one patient moved away, one patient was discharged due to drug abuse, one patient was lost to follow-up. Furthermore, 8 patients were nonresponsive or moved to medical therapy due to other reasons or lack of their interest in undergoing further treatments with the percutaneous adhesiolysis. Overall, 7 patients had no follow-up after the first or second visit. Consequently, the data was extrapolated with intent-to-treat analysis in 20 patients at various periods.

Ten of the 70 patients received only one or 2 treatments due to failure to respond appropriately.

Recruitment
-----------

The recruitment period lasted from January 2006 to June 2010.

Baseline Data
-------------

Demographic and clinical characteristics are illustrated in Table [1](#T1){ref-type="table"}.

Therapeutic Procedural Characteristics
--------------------------------------

Therapeutic procedural characteristics with average pain relief per procedure are illustrated in Table [2](#T2){ref-type="table"}. The average pain relief per procedure was 13.2 ± 12.6 weeks. The average number of procedures was 3 to 4 per year, and 5 to 6 for 2 years. Total relief for 2 years was 71.1 ± 37.4 weeks over a period of 104 weeks. Only 2 patients received long-term relief with one patient with one treatment with 2 years of relief, and another patient with 2 treatments with 2 years of relief.

Outcomes
--------

### Pain Relief

Table [3](#T3){ref-type="table"} and Figure [1](#F1){ref-type="fig"} illustrate the proportion of patients with significant pain relief and functional status improvement. The primary outcome measure of 50% improvement with NRS and ODI was seen in 71% of patients at the end of 2 years. There was also a significant difference noted in NRS and ODI scores from baseline to various assessment periods of 3, 6, 12, 18, and 24 months.

Opioid Intake
-------------

Opioid intake is described in Table [4](#T4){ref-type="table"}. Opioid intake was reduced at 3, 6, 12, 18, and 24 month follow-up periods compared to baseline.

Characteristics of Weight Monitoring
------------------------------------

Characteristics of weight monitoring are described in Table [5](#T5){ref-type="table"}. There was no significant change in the overall weight at the end of one year or two years. Twenty-three percent gained weight, 54% lost weight, and 23% remained the same. At the end of 2 years, 27% gained weight, 57% lost weight, and 16% were with no change in their weight.

Employment Characteristics
--------------------------

There were only 4 patients eligible for employment at baseline. Of these, 2 were employed at baseline. At the end of one year and 2 years, 3 were employed.

Adverse Events
--------------

There were no major adverse events reported over a period of 2 years. Subarachnoid puncture was noted on 6 instances with weakness developing in 2 patients with no long-term sequelae or post lumbar puncture headache.

Discussion
==========

This study was a prospective evaluation of the effectiveness of percutaneous adhesiolysis with targeted delivery of injectate in 70 patients suffering from lumbar central stenosis with a 2-year follow-up. The results showed a successful primary outcome measure with a significant reduction of pain and improvement in function in 71% of the patients at the end of 2 years. The results were similar to the previous evaluation of a randomized trial [@B32] in which 76% of patients in the adhesiolysis group showed over 50% pain relief and functional improvement. The average procedures for 2 years were 5.7 ± 2.73. The average relief over a period of 2 years was 71.1 ± 37.4 weeks over a period of 104 weeks. The results of this observational study illustrate that percutaneous adhesiolysis with targeted delivery of injectate is superior to either caudal or lumbar interlaminar epidural injections in central spinal stenosis, specifically in those who have failed to respond to fluoroscopically directed caudal or lumbar epidural injections [@B24],[@B25],[@B28],[@B29].

This study may be criticized for the lack of a control group and inclusion of less than 100 patients in an observational study. In conducting this study, however, specifically with the randomized phase, we faced multiple issues with recruitment, continuation in the study without unblinding despite the lack of pain relief and long-term follow-up. Consequently, the consideration of central spinal stenosis after a failure to respond to fluoroscopically directed epidural injections is a difficult management issue. We consider that 70 patients in the observational phase with a 2-year follow-up is appropriate. The number of patients who withdrew or were not available for follow-up at the end of 2 years was less than 30%, which is acceptable based on Cochrane review criteria for randomized trials [@B64]. On the issue of placebo control, the difficulties are insurmountable when utilizing interventional techniques in the United States. These difficulties contributed to our failure to complete the study as expected. Damen et al [@B65] reviewed the issue of terminating clinical trials due to an insufficient number of subjects. They noted that the research question is unlikely to be answered reliably if the requisite number of subjects is not met, and that the continued participation of the study participants at inadequate levels may expose patients to unnecessary risks and burdens. The results of this study [@B65] showed that a considerable proportion of studies (41 of 107) were terminated due to failure to recruit a sufficient number of subjects. Furthermore, the authors found that investigator-initiated studies have significantly more problems when recruiting the requisite number of subjects than studies initiated by pharmaceutical companies. This may be due to the remuneration offered in pharmaceutical studies when compared with investigator-initiated studies. Our experience has been to the contrary when recruiting required subjects. Of the 16 studies performed by these investigators, this was the first study for which the required number of patients was not recruited. The major issue has been placebo control groups, for which patients are difficult to recruit. Consequently, active-control groups facilitate easier recruitment and also short-term follow-up will facilitate the recruitment. In addition, Damen et al [@B65] found that 40% of study results were published with the inclusion of the correct number of subjects, compared with 32% of studies where the requisite number of subjects was not obtained. Nevertheless, protocol violations were reported only twice. Consequently, in this evaluation, all information has been provided so that the study may be assessed appropriately. The study was converted into an observational study as to avoid having to subject patients to enrollment and subsequent withdrawal.

An observational study is defined as an etiologic or effectiveness study [@B66]. Even though in the paradigm of evidence-based medicine (EBM) randomized trials have been considered as the highest quality of evidence, EBM by no means is limited to randomized trials only. The World Health Organization (WHO) defines clinical trials as, "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes [@B67]." Thus, to improve the effectiveness and safety of patient care, there is a growing emphasis on evidence-based interventional pain management and the incorporation of high quality evidence into clinical practice including observational studies. Furthermore, the majority of studies in interventional pain management are observational and treatments, including surgery, are more likely to be based on observational studies than are those in internal medicine, which are based on randomized controlled trials. The basis for randomized trials arises from the evidence that many surgical and medical interventions recommended that were based on observational studies have later been demonstrated to be ineffective or even harmful [@B68]-[@B72]. However, contradictory evidence has been demonstrated for randomized control trials also [@B49],[@B73]. The evidence from observational studies has been shown to be viable in multiple reviews. The poor quality of reporting in observational intervention studies was reported as a potential factor for confounding bias in 98% of studies [@B74]. In a 2005 publication, Hartz et al [@B75] assessed observational studies of medical treatments and concluded that reporting was often inadequate for use in comparing the study designs or allowing for any other meaningful interpretation of the results. However, the concept that the assignment of subjects randomly to either experimental or control groups is a perfect science also has been questioned. In contrast to Hartz et al\'s assessment in 2005 [@B75], Benson and Hartz [@B76] in a 2000 publication comparing observational studies and randomized controlled trials found little evidence that estimates of treatment effects in observational studies reported after 1984, were either consistently larger than or qualitatively different from those obtained in randomized controlled trials. Furthermore, Hartz et al [@B77], in a 2003 publication assessing observational studies of chemonucleolysis, concluded that the results suggested that a review of several comparable observational studies may help evaluate treatment, identify patient types most likely to benefit from a given treatment, and provide information about study features that can improve the design of subsequent observational studies or even randomized controlled trials. However, they caution that the potential of comparative observational studies has not been realized because of concurrent inadequacies in their design, analysis, and reporting. Concato et al [@B78] in a 2000 publication evaluating published articles in 5 major medical journals from 1991 to 1995, concluded that the results of well-designed observational studies do not systematically overestimate the magnitude of the effects of treatment as compared with those of randomized controlled trials on the same topic. In fact, Shrier et al [@B79] in 2007, found that the advantages of including both observational studies and randomized trials in a meta-analysis could outweigh the disadvantages in many situations and that observational studies should not be excluded a priori. In addition, an assessment of the methodological quality of observational studies has been described extensively [@B24]-[@B27],[@B49],[@B80]. Thus, observational studies are important in assessing the effectiveness of interventions.

The mechanism of neural blockade has been described to be complex with alternation or interruption of nociceptive input, the reflex mechanism of afferent fibers, self-sustaining activity of the neurons, and the pattern of central neuronal activities [@B81]. Among the multiple drugs utilized in this procedure, corticosteroids have been shown to reduce inflammation by inhibiting the synthesis of a number of pro-inflammatory mediators [@B82]-[@B84]. Local anesthetics also have shown to provide short to long-term symptomatic relief based on various mechanisms including suppression of nociceptive discharge, blockade of the sympathetic reflex arch, block of axonal transport of nerve fibers, and anti-inflammatory effects [@B85]-[@B90]. In addition, local anesthetics and steroids also provided similar relief when they were injected individually in experimental settings [@B91],[@B92] and also in multiple clinical settings [@B26],[@B28],[@B29],[@B32],[@B43],[@B54]-[@B63],[@B81]. Finally, hypertonic sodium chloride solution has been shown to provide neurolysis and analgesia by various mechanisms [@B43],[@B46]. While the results in this study are shown to improve patients after they have failed conservative modalities including fluoroscopically directed epidural injections, the role of percutaneous adhesiolysis in foraminal stenosis without central spinal stenosis is not known. The results of this evaluation are only limited to central spinal stenosis without surgical interventions. It is interesting to evaluate the role of each component of percutaneous adhesiolysis in reference to adhesiolysis, injection of local anesthetic, injection of steroids, and injection of hypertonic sodium chloride solution.

Overall, the results of this observational study of 70 patients with a long-term follow-up of 2 years show that percutaneous adhesiolysis may be an effective modality in patients failing to respond to fluoroscopically directed epidural injections and also other conservative modalities of treatment.

Conclusion
==========

This observational study showed that 71% of 70 patients met the primary outcome measure with an improvement in physical and functional status of at least 50%. Consequently, the results of this study show that percutaneous adhesiolysis in central spinal stenosis without surgical intervention after failure of conservative modalities including fluoroscopically directed epidural injections may be an effective modality.
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###### 

Baseline demographic and clinical data.

                                                       Number (70)
  ------------------------------------ --------------- ---------------
  Gender                               Male            43% (30)
  Female                               57% (40)        
  Age                                  Mean ± SD       57.2 ± 13.7
  Height (inches)                      Mean ± SD       66.5 ± 3.9
  Weight (lbs)                         Mean ± SD       181.2 ± 48.1
  Pain Duration (months)               Mean ± SD       144.1 ± 136.3
  Mode of onset of Pain                Non-traumatic   77% (54)
  Traumatic                            23% (16)        
  Baseline Average Pain Score          Mean ± SD       8.0 ± 0.83
  Baseline Oswestry Disability Index   Mean ± SD       31.1 ± 4.10
  Back Pain Distribution               Bilateral       85% (59)
                                       Left or Right   15% (11)
  Leg Pain Distribution                Bilateral       50% (35)
                                       Left or Right   50% (35
  Spinal stenosis severity             Mild            27% (19)
  Moderate                             36% (25)        
  Severe                               37% (26)        

###### 

Therapeutic procedural characteristics with average relief per procedure, and average total relief in weeks over a period of 2 years.

  -----------------------------------------------------------
                                               Number\
                                               (70)
  -------------------------------------------- --------------
  **At One Year**                              

  Average number of procedures per one year    3.3 ± 1.07

  Total number of procedures in one year       233

  Average total relief per one year (weeks)    40.7 ± 19.62

  **At Two Years**                             

  Average number of procedures per two years   5.7 ± 2.73

  Total number of procedures in two years      397

  Average total relief per two years (weeks)   71.1 ± 37.4

  **Average Relief per Procedure**             13.2 ± 12.6
  -----------------------------------------------------------

###### 

Comparison of Numeric Rating Scale for pain and Oswestry Disability Index score summaries at six time points.

  ------------------------------------------------------------------------------------------
  Time Points                    Numeric Pain Rating Score\   *Oswestry Disability Index*\
                                 Mean ± SD                    Mean ± SD
  ------------------------------ ---------------------------- ------------------------------
  Baseline                       8.0 ± 0.83                   31.1 ± 4.10

  3 months                       3.6^\#^ ± 1.10\              15.3^\#^ ± 4.90\
                                 (84%)                        (80%)

  6 months                       3.8^\#^ ± 1.15\              15.6^\#^ ± 4.62\
                                 (79%)                        (71%)

  12 months                      4.0^\#^ ± 1.27\              15.9^\#^ ± 5.00\
                                 (69%)                        (66%)

  18 months                      3.9^\#^ ± 1.35\              15.5^\#^ ± 5.12\
                                 (73%)                        (73%)

  24 months                      4.2^\#^ ± 1.90\              15.3^\#^ ± 5.36\
                                 (71%)                        (73%)

  Baseline vs follow-up points   0.001                        0.001
  ------------------------------------------------------------------------------------------

Percentages in parenthesis illustrates proportion with significant pain relief (≥ 50%) from baseline

\* indicates significant difference with baseline values (*P* \< 0.05)

###### 

Opioid intake (morphine equivalence mg).

  -----------------------------------------------
  Narcotic intake\               Total         
  (Morphine Equivalence mg)                    
  ------------------------------ ------------- --
  Baseline                       59 ± 48.4     

  3 months                       41\* ± 35.4   

  6 months                       41\* ± 35.9   

  12 months                      43\* ± 37.4   

  18 months                      42\* ± 36.4   

  24 months                      43\* ± 37.4   

  Baseline vs follow-up points   0.001         
  -----------------------------------------------

\* indicates significant difference with baseline values (p \< 0.05)

###### 

Characteristics weight monitoring.

  Weight (lbs)           
  ---------------------- ---------------
  Weight at Beginning    181.2 ± 48.06
  At one year            
  Weight at one year     175.7 ± 46.25
  Change from baseline   -5.4 ± 13.53
  No change              23%
  Gained weight          23%
  Lost weight            54%
  At two years           
  Weight at two years    175.7 ± 48.63
  Change from baseline   -5.4 ± 17.04
  No change              16%
  Gained weight          27%
  Lost weight            57%
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